Want to see IN:SAGILITY full AI Analyst Report?
Top Page
Sagility India Limited
(SAGILITY)
Select Model
Select Model
Rating:68Neutral
Price Target:
₹46.00
▲(1.91% Upside)
Action:Downgraded
Date:08/17/26
The score is driven primarily by improving fundamentals: strong revenue scale-up, materially better profitability, and a significantly de-risked balance sheet. This is tempered by inconsistencies in margin/cash conversion quality and a mixed technical picture with neutral momentum and limited near-term strength. Valuation is moderate with a low dividend yield, providing neither a strong discount nor major support.
Positive Factors
Strong Revenue Scale-Up
The substantial multi-year revenue expansion indicates growing healthcare-services scale and client demand. Continued growth provides operating leverage, supports investment in delivery capabilities, and strengthens Sagility’s position in outsourced healthcare workflows.
Negative Factors
Gross-Margin Volatility
Inconsistent gross-margin reporting or performance makes the underlying economics harder to assess. If driven by service mix, pricing, or delivery costs, sustained volatility could limit confidence in margin durability despite stronger EBITDA and net profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Scale-Up
The substantial multi-year revenue expansion indicates growing healthcare-services scale and client demand. Continued growth provides operating leverage, supports investment in delivery capabilities, and strengthens Sagility’s position in outsourced healthcare workflows.
Read all positive factors
Sagility India Limited (SAGILITY) vs. iShares MSCI India ETF (INDA)
Market Cap
₹197.79B
Dividend Yield0.35%
Average Volume (3M)3.66M
Price to Earnings (P/E)19.9
Beta (1Y)1.14
Revenue Growth29.43%
EPS Growth49.23%
CountryIN
Employees47,307
SectorGeneral
Sector StrengthN/A
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)2.13
Shares Outstanding4,681,328,600
10 Day Avg. Volume1,944,546
30 Day Avg. Volume3,661,904
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)1.93
Price to Sales (P/S)2.59
P/FCF Ratio19.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.61
Revenue Forecast (FY)₹86.94B
Sagility India Limited Business Overview & Revenue Model
Company Description
Headquartered in Bengaluru, India, and established in 2021, Sagility India Limited specializes in providing comprehensive business process management (BPM) services. The company primarily caters to clients within the healthcare and insurance indus...
How the Company Makes Money
Sagility primarily makes money by delivering outsourced, technology-enabled business services to healthcare organizations under long-term service contracts. Revenue is generated from fees charged for executing specific processes (e.g., contact-cen...
Sagility India Limited Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
82
Very Positive
Cash Flow
71
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 76.17B | 71.93B | 55.70B | 47.54B | 42.18B | 13.85B |
| Gross Profit | 13.52B | 26.83B | 14.45B | 47.54B | 17.15B | 5.99B |
| EBITDA | 19.07B | 18.25B | 12.98B | 11.16B | 10.45B | 2.42B |
| Net Income | 9.93B | 9.25B | 5.39B | 2.28B | 1.44B | -70.06M |
Balance Sheet | ||||||
| Total Assets | 127.88B | 126.01B | 110.51B | 106.64B | 105.90B | 100.96B |
| Cash, Cash Equivalents and Short-Term Investments | 9.67B | 9.04B | 3.44B | 3.44B | 5.85B | 3.74B |
| Total Debt | 10.89B | 11.11B | 14.02B | 25.32B | 28.96B | 47.33B |
| Total Liabilities | 28.62B | 29.42B | 27.15B | 42.21B | 43.84B | 60.70B |
| Stockholders Equity | 99.27B | 96.59B | 83.36B | 64.43B | 62.07B | 40.27B |
Cash Flow | ||||||
| Free Cash Flow | 12.33B | 9.66B | 10.90B | 7.91B | 7.13B | -584.19M |
| Operating Cash Flow | 14.99B | 11.58B | 12.14B | 9.73B | 8.57B | -478.38M |
| Investing Cash Flow | -8.68B | -7.24B | -9.64B | -4.69B | -1.29B | -77.14B |
| Financing Cash Flow | -5.31B | -4.43B | -2.56B | -7.51B | -5.45B | 81.17B |
Sagility India Limited Technical Analysis
Neutral
45.14
Price Trends
41.46
Positive
41.50
Positive
44.91
Negative
Market Momentum
0.33
Positive
48.56
Neutral
10.95
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SAGILITY, the sentiment is Neutral. The current price of 45.14 is above the 20-day moving average (MA) of 43.04, above the 50-day MA of 41.46, and above the 200-day MA of 44.91, indicating a neutral trend. The MACD of 0.33 indicates Positive momentum. The RSI at 48.56 is Neutral, neither overbought nor oversold. The STOCH value of 10.95 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:SAGILITY.
Sagility India Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹133.67B | 33.64 | ― | 0.41% | 30.41% | -8.20% | |
72 Outperform | ₹307.95B | 40.10 | ― | ― | ― | ― | |
68 Neutral | ₹197.79B | 19.91 | ― | ― | 29.43% | 49.23% | |
59 Neutral | ₹26.08B | 26.98 | ― | ― | 27.41% | -5.05% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
52 Neutral | ₹80.34B | 37.41 | ― | ― | 16.79% | 17.67% | |
42 Neutral | ₹3.50B | 27.01 | ― | ― | ― | -68.52% |
* General Sector Average
IN:SAGILITY
Sagility India Limited
42.40
-3.25
-7.12%
IN:INDGN
Indegene Limited
562.25
-23.08
-3.94%
IN:MEDIASSIST
Medi Assist Healthcare Services Limited
343.35
-189.05
-35.51%
IN:MEDPLUS
MedPlus Health Services Ltd.
655.00
-176.80
-21.26%
IN:TAKE
TAKE Solutions Limited
23.48
13.55
136.46%
IN:IKS
Inventurus Knowledge Solutions Limited
1,830.05
248.25
15.69%
Sagility India Limited Corporate Events
Sagility clears Q1 FY27 unaudited results with limited review
Jul 21, 2026
Sagility Limited announced that its Board of Directors has approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The disclosure was made in line with Regulation 33 of SEBI’s Listing Obligat...
Sagility posts robust Q1 FY27 growth and expands healthcare operations footprint
Jul 21, 2026
Sagility Limited reported strong unaudited results for Q1 FY27, with revenue rising 27.6% year-on-year to INR 19,635 million and adjusted EBITDA growing 27.9%, maintaining a 24.0% margin. Adjusted PAT climbed 35.1% and earnings per share rose shar...
Sagility to Host Q1 FY27 Earnings Webinar for Investors on July 21
Jul 13, 2026
Sagility Limited has announced that it will host an earnings webinar for analysts and investors to discuss its unaudited financial results for the quarter ended June 30, 2026. The session, scheduled for July 21, 2026 at 7:30 p.m. IST via Zoom, wil...
Sagility Sets AGM Date and Record Date for FY 2025-26 Final Dividend
Jul 9, 2026
Sagility Limited has scheduled its Annual General Meeting for August 20, 2026, to be held via video conferencing, with the detailed notice and annual report for FY 2025-26 to be circulated separately. The company has set August 7, 2026, as the rec...
Sagility Sets August 20 Virtual AGM and Final Dividend Record Date
Jul 9, 2026
Sagility Limited has scheduled its fifth Annual General Meeting for August 20, 2026, at 4:00 p.m. IST, to be conducted through video conferencing and other audio-visual means, with the detailed notice and annual report for FY 2025-26 to be circula...
Sagility Clarifies Performance-Linked Structure of 2026 ESOP and PSU Plan
Jun 19, 2026
Sagility Limited has issued additional clarifications on its proposed Employee Stock Options and Performance Stock Units Scheme 2026, detailing a performance framework that ties at least 70% of incentives, especially for senior management, to core...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.